In Situ Hybridization Market Outlook:
In Situ Hybridization Market size was over USD 1.73 Billion in 2025 and is poised to exceed USD 3.5 Billion by 2035, growing at over 7.3% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of in situ hybridization is estimated at USD 1.84 Billion.
The reason behind the growth is due to the rising incidence of cancer across the globe. Fluorescence in situ hybridization also known as FISH scans cells for alterations in genes can aid in cancer diagnosis and can be used to track treatment response and illness remission. In 2040, there will likely be more than 28 million new instances of cancer worldwide.
The growing technological advancements in In-vitro diagnostics (IVD) are believed to fuel the market growth. For instance, Artificial intelligence (AI) technology integration in oncology-based in vitro diagnostic (IVD) technologies has the potential to significantly enhance healthcare decisions by identifying disease signatures that can aid in early detection and treatment, and by identifying central nervous system (CNS) cancers by predicting which therapy responses will be most successful using patient samples.
